Dow and S&P 500 Trade Higher on Moderna Vaccine News

This post was originally published on this site
Stocks jump after Moderna says its coronavirus vaccine candidate was 94.5% effective in a late-stage clinical trial.

Stocks jumped Monday after Moderna  (MRNA) – Get Report said its coronavirus vaccine candidate was 94.5% effective in a late-stage clinical trial.

Moderna’s efficacy rate topped the 90% efficacy rate reported by Pfizer  (PFE) – Get Report last week. The company noted the vaccine can last for up to six months when stored at standard freezer temperatures.

Drugmaker Moderna said it expects to apply for emergency use authorization with the U.S. Food and Drug Administration within the coming weeks. Moderna shares rose 4.77%.

The Dow Jones Industrial Average rose 290 points, or 0.98%, to 29,770, the S&P 500 gained 0.67% to 3,609, and the Nasdaq was up 0.44% but gains were held in check as many tech stocks that benefited from virus-related lockdowns traded lower.

“Additional positive news on the Covid-19 vaccine front is more evidence that an end to the pandemic is on the horizon and that the economy can eventually reopen without fears of further lockdowns,” said David Trainer, CEO of Nashville-based investment research firm New Constructs.

Stocks had been higher during the premarket session after advisers to President-elect Joe Biden said they opposed a nationwide lockdown but preferred targeted measures to control the surge in U.S. coronavirus cases.

The S&P 500 closed at a record high of 3,585 on Friday and rose 2.2% for the week on rising optimism over a coronavirus vaccine. The U.S. over the weekend topped 11 million known cases of Covid-19, the disease caused by the coronavirus.

Vivek Murthy, who serves as co-chair of Biden’s coronavirus advisory board, said strict lockdowns aren’t always necessary if people comply with less restrictive measures such as wearing masks and social distancing.

“If we just lock down the entire country without targeting our efforts, then we are going to exacerbate the ‘pandemic fatigue’ people are feeling, you’re going to hurt jobs and the economy, you’re going to shut down schools and hurt the education of our children,” Murthy, a former U.S. surgeon general, told “Fox News Sunday.”

Stocks also received a boost from better-than-expected economic data from both Japan and China.

Shares of HD Supply Holdings  (HDS) – Get Report soared to an all-time high Monday after agreeing an $8 billion takeover by Home Depot  (HD) – Get Report.

Home Depot, the world’s biggest home-improvement retailer, said it would pay $56 a share for HD Supply, which distributes tools and products to the maintenance and construction sector. That’s a 25% premium to HD’s closing price on Friday and values the Atlanta-based HDS at around $8 billion including debt. 

PNC Financial Services  (PNC) – Get Report reached an agreement to acquire the U.S. banking operations of Spain’s BBVA for $11.6 billion.

Big box retailers Home Depot, Walmart WMT and Target TGT are scheduled to report earnings this week in a season that has been stronger than expected.

With just more than 92% of the S&P 500 reporting far, third-quarter earnings are set to decline around 7.4% from last year, a much better result than the 21.4% forecast prior to the start of the reporting in early October. The early estimate for fourth-quarter earnings, meanwhile, suggests an 11% decline from a year earlier.